SALSA MLPA P055 PAH probemix - 50 reactions

application: Phenylketonuria
region: PAH 12q24.1 Detailní informace

Cena s DPH € 573.54
Cena bez DPH € 474.00
 50 react
Dostupnost Skladem
Kód produktu P055-050R

Nejnovější informace o produktu naleznete exklusivně na stránkách výrobce MRC-Holland www.mlpa.com (nové okno)

Detailní popis SALSA MLPA P055 PAH probemix - 50 reactions

P055-050R SALSA MLPA P055 PAH probemix – 50 rxn

PHENYLKETONURIA is an inborn error of metabolism resulting from a deficiency of phenylalanine hydroxylase and characterized by mental retardation. Early diagnosis of phenylketonuria (PKU), a cause of mental retardation, is important because it is treatable by diet. Other features in untreated patients include a 'mousy' odor; light pigmentation; peculiarities of gait, stance, and sitting posture; eczema; and epilepsy (Paine, R. 1957). Kawashima et al. (1988) suggested that cataracts and brain calcification may be frequently overlooked manifestations of classic untreated PKU.

The basic defect in PKU is phenylalanine hydroxylase deficiency. Evidence of heterogeneity in phenylketonuria was presented by Auerbach et al. (1967). The PAH gene located on chromosome 12q24.1 is 90 kb long and codes for a mature mRNA of 2.4 kb. Recurrent mutations had been observed at several sites, producing associations with different haplotypes in different populations. Studies of in vitro expression showed significant correlations between residual PAH activity and severity of the disease phenotype.

This P055-C1 PAH probemix contains probes for all of the 13 coding exons of the PAH gene. In addition 2 probes for the neighbouring genes ASCL1 (upstream PAH) and IGF1 (downstream PAH) are included. For data analysis, 14 reference probes located on other chromosomes are included.
This SALSA MLPA kit is not intended to be used for initial diagnosis of PKU. Most defects in the PAH gene are point mutations, the majority of which will not be detected by MLPA. Therefore, it is recommended to use this SALSA MLPA kit in conjunction with sequence analysis.

This SALSA® MLPA® probemix is designed to detect deletions/duplications of one or more sequences in the aforementioned genes in a DNA sample. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak area of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak area, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings. We have no information on what percentage of defects in these genes is caused by deletions/duplications of complete exons. Finally, note that most defects in this gene are expected to be small (point) mutations which will not be detected by this SALSA® MLPA® test.

Produkt je zařazen v následujících kategoriích

Kontaktujte nás

BIOGEN PRAHA s.r.o.
Ke sv. Izidoru 2293/4A
140 00 PRAHA 4

Tel.: +420 241 401 693
Fax: +420 241 401 694
E-mail: biogen@biogen.cz

Novinky na e-mail

Vaše osobní údaje nejsou nikde zveřejňovány a splňují požadavky GDPR.